PerCP/Cyanine5.5 anti-human CD101 (BB27) Antibody

PerCP/Cyanine5.5 anti-human CD101 (BB27) Antibody Suppliers list
Company Name: BioLegend Inc  
Tel: 03-+44 20 3475 3880 1-858-455-9588
Email: cs@biolegend.com
Products Intro: Product Name:PerCP/Cyanine5.5 anti-human CD101 (BB27) Antibody
PerCP/Cyanine5.5 anti-human CD101 (BB27) Antibody Basic information
Product Name:PerCP/Cyanine5.5 anti-human CD101 (BB27) Antibody
Synonyms:PerCP/Cyanine5.5 anti-human CD101 (BB27) Antibody
CAS:
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
PerCP/Cyanine5.5 anti-human CD101 (BB27) Antibody Structure
PerCP/Cyanine5.5 anti-human CD101 (BB27) Antibody Chemical Properties
Safety Information
MSDS Information
PerCP/Cyanine5.5 anti-human CD101 (BB27) Antibody Usage And Synthesis
PerCP/Cyanine5.5 anti-human CD101 (BB27) Antibody Preparation Products And Raw materials
Tag:PerCP/Cyanine5.5 anti-human CD101 (BB27) Antibody Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.
This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept